FDA To Study How Proprietary Drug Names Affect Public Perception

FDA plans to study how proprietary drug names affect public perception and how they can sometimes be misleadingly overstate the safety or efficacy of the drug, expand drug indications or suggest superiority, the agency told the White House budget office on Friday (Jan. 17). The study will be the first to systematically investigate a variety of proprietary prescription drug names, the agency told the Office of Management and Budget. The proposed study, “Empirical Study of Promotional Implications of Proprietary Prescription...